207 related articles for article (PubMed ID: 9597800)
81. Multiple myeloma.
J Tenn Med Assoc; 1978 May; 71(5):357-61. PubMed ID: 661303
[No Abstract] [Full Text] [Related]
82. Approach to High-Risk Multiple Myeloma.
Chen X; Varma G; Davies F; Morgan G
Hematol Oncol Clin North Am; 2024 Apr; 38(2):497-510. PubMed ID: 38195306
[TBL] [Abstract][Full Text] [Related]
83. Multiple myeloma.
Seiden MV; Anderson KC
Curr Opin Oncol; 1994 Jan; 6(1):41-9. PubMed ID: 7515694
[TBL] [Abstract][Full Text] [Related]
84. Multiple Myeloma.
Levitt DZ
Am J Nurs; 1981 Jul; 81(7):1345. PubMed ID: 6910339
[No Abstract] [Full Text] [Related]
85. [Controversies and progress in the treatment of multiple myeloma].
Robak T
Pol Tyg Lek; 1990 May 21-28; 45(21-22):407-11. PubMed ID: 2267190
[No Abstract] [Full Text] [Related]
86. Advances in biology of multiple myeloma: cell kinetics, molecular biology and immunology.
Pileri A; Ferrero D; Massaia M; Dianzani U; Boccadoro M
Eur J Haematol Suppl; 1989; 51():30-4. PubMed ID: 2697592
[TBL] [Abstract][Full Text] [Related]
87. Developmental therapeutics for multiple myeloma--a road map for the future.
Shaughnessy JD; Barlogie B
Semin Hematol; 2001 Jul; 38(3):295-7. PubMed ID: 11486318
[No Abstract] [Full Text] [Related]
88. [Biology of multiple myeloma].
Ciepłuch H
Wiad Lek; 1994 Apr; 47(7-8):299-301. PubMed ID: 7941584
[No Abstract] [Full Text] [Related]
89. International Myeloma Working Group recommendations for global myeloma care.
Ludwig H; Miguel JS; Dimopoulos MA; Palumbo A; Garcia Sanz R; Powles R; Lentzsch S; Ming Chen W; Hou J; Jurczyszyn A; Romeril K; Hajek R; Terpos E; Shimizu K; Joshua D; Hungria V; Rodriguez Morales A; Ben-Yehuda D; Sondergeld P; Zamagni E; Durie B
Leukemia; 2014 May; 28(5):981-92. PubMed ID: 24177258
[TBL] [Abstract][Full Text] [Related]
90. [Current progress in multiple myeloma and tumor vascular targeting therapy].
Wu C; Cai Z
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):363-6. PubMed ID: 23668215
[No Abstract] [Full Text] [Related]
91. Integration of Genomics Into Treatment: Are We There Yet?
Morgan GJ; Jones JR
Am Soc Clin Oncol Educ Book; 2017; 37():569-574. PubMed ID: 28561666
[TBL] [Abstract][Full Text] [Related]
92. Introduction by the Guest Editor: Recent advances in biology and treatment of multiple myeloma.
Tanaka H
Int J Hematol; 2020 Apr; 111(4):494-495. PubMed ID: 31984452
[No Abstract] [Full Text] [Related]
93. Advancements in Nanomedicine for Multiple Myeloma.
Detappe A; Bustoros M; Mouhieddine TH; Ghoroghchian PP
Trends Mol Med; 2018 Jun; 24(6):560-574. PubMed ID: 29773319
[TBL] [Abstract][Full Text] [Related]
94. The biology of multiple myeloma.
Durie BG
Hematol Oncol; 1988; 6(2):77-81. PubMed ID: 3292379
[No Abstract] [Full Text] [Related]
95. Proceedings of the International Conference on Multiple Myeloma. Biology, pathophysiology, prognosis and treatment. June 19-22, 1989, Bologna, Italy.
Eur J Haematol Suppl; 1989; 51():1-195. PubMed ID: 2627986
[No Abstract] [Full Text] [Related]
96. [Risk stratification and target therapies in multiple myeloma].
Chen SL
Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):195-7. PubMed ID: 20450647
[No Abstract] [Full Text] [Related]
97. [Cardiac involvement in multiple myeloma].
Sivriev L; Kutev D; Gabrovska Zh; Pandev S
Vrach Delo; 1972 May; 5():100-1. PubMed ID: 5029772
[No Abstract] [Full Text] [Related]
98. Optimizing multiple myeloma treatment: conclusions.
Palumbo A
Leuk Res; 2012 Nov; 36 Suppl 1():S44-5. PubMed ID: 23176724
[No Abstract] [Full Text] [Related]
99. From Bench to Bedside: The Evolution of Genomics and Its Implications for the Current and Future Management of Multiple Myeloma.
Morgan GJ; Boyle EM; Davies FE
Cancer J; 2021 May-Jun 01; 27(3):213-221. PubMed ID: 34549910
[TBL] [Abstract][Full Text] [Related]
100. Unraveling the multiple myeloma genome in the next-generation sequencing era: challenges to translating knowledge into the clinic.
Braggio E; Fonseca R
Expert Rev Hematol; 2011 Dec; 4(6):579-81. PubMed ID: 22077519
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
